Corcept Therapeutics Inc
CORT
$73.095-0.90 (-1.21%)
Jun 26, 2025, 12:31 PM
Financials
| 52Week High | 117.33 | 52Week Low | 29.42 |
| Beta | 0.22 | Current Ratio Annual | 3.35 |
| Current Ratio Quarterly | 3.07 | Gross Margin TTM | 98.43 |
| Market Cap | 7.88B | Net Profit Margin TTM | 19.55 |
| Operating Margin TTM | 16.17 | Price To Book | 11.53 |
| Price To Earnings TTM | 58.79 | Price To Free Cash Flow TTM | 44.46 |
| Price To Sales TTM | 11.49 | Quick Ratio Annual | 3.19 |
| Quick Ratio Quarterly | 2.90 | Return On Assets TTM | 16.82 |
| Return On Equity TTM | 20.63 | Return On Investment TTM | 20.63 |
| Revenue Growth3Y | 22.64 | Revenue Growth5Y | 17.11 |
| Revenue Growth Quarterly Yoy | 7.09 | Revenue Growth TTMYoy | 30.93 |
| Revenue Per Share TTM | 5.72 |
| Quarter | Funds | Added | Exited | Increased | Decreased | Unchanged | Shares | Value |
|---|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | 375 | 2 | 0 | 6 | 5 | 1 | 86.65M | $3.86B |
| Mar 31, 2025 | 418 | 103 | 51 | 128 | 140 | 41 | 86.66M | $8.53B |
| Change | 43(11%) | 101(5050%) | 51 | 122(2033%) | 135(2700%) | 40(4000%) | 9K(0%) | $4.67B(121%) |